Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Insmed Incorporated stock | $27.45

Learn how to easily invest in Insmed Incorporated stock.

Insmed Incorporated is a biotechnology business based in the US. Insmed Incorporated shares (INSM) are listed on the NASDAQ and all prices are listed in US Dollars. Insmed Incorporated employs 521 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Insmed Incorporated

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – INSM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Insmed Incorporated stock price (NASDAQ: INSM)

Use our graph to track the performance of INSM stocks over time.

Insmed Incorporated shares at a glance

Information last updated 2021-10-25.
Latest market close$27.45
52-week range$22.00 - $45.44
50-day moving average $27.31
200-day moving average $27.70
Wall St. target price$52.20
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.60

Buy Insmed Incorporated shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Insmed Incorporated stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Insmed Incorporated price performance over time

Historical closes compared with the close of $27.45 from 2021-10-22

1 week (2021-10-18) 4.14%
1 month (2021-09-24) 1.63%
3 months (2021-07-26) 14.85%
6 months (2021-04-26) -23.77%
1 year (2020-10-23) -25.79%
2 years (2019-10-25) 50.00%
3 years (2018-10-25) 75.85%
5 years (2016-10-25) 95.23%

Insmed Incorporated financials

Revenue TTM $170.6 million
Gross profit TTM $33.9 million
Return on assets TTM -19.1%
Return on equity TTM -80.06%
Profit margin -219.67%
Book value $4.61
Market capitalisation $3.2 billion

TTM: trailing 12 months

Shorting Insmed Incorporated shares

There are currently 8.8 million Insmed Incorporated shares held short by investors – that's known as Insmed Incorporated's "short interest". This figure is 1.5% up from 8.7 million last month.

There are a few different ways that this level of interest in shorting Insmed Incorporated shares can be evaluated.

Insmed Incorporated's "short interest ratio" (SIR)

Insmed Incorporated's "short interest ratio" (SIR) is the quantity of Insmed Incorporated shares currently shorted divided by the average quantity of Insmed Incorporated shares traded daily (recently around 813204.97695853). Insmed Incorporated's SIR currently stands at 10.85. In other words for every 100,000 Insmed Incorporated shares traded daily on the market, roughly 10850 shares are currently held short.

However Insmed Incorporated's short interest can also be evaluated against the total number of Insmed Incorporated shares, or, against the total number of tradable Insmed Incorporated shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Insmed Incorporated's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Insmed Incorporated shares in existence, roughly 80 shares are currently held short) or 0.0963% of the tradable shares (for every 100,000 tradable Insmed Incorporated shares, roughly 96 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Insmed Incorporated.

Find out more about how you can short Insmed Incorporated stock.

Insmed Incorporated share dividends

We're not expecting Insmed Incorporated to pay a dividend over the next 12 months.

Have Insmed Incorporated's shares ever split?

Insmed Incorporated's shares were split on a 1:10 basis on 2 March 2011. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Insmed Incorporated shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Insmed Incorporated shares which in turn could have impacted Insmed Incorporated's share price.

Insmed Incorporated share price volatility

Over the last 12 months, Insmed Incorporated's shares have ranged in value from as little as $22 up to $45.44. A popular way to gauge a stock's volatility is its "beta".

INSM.US volatility(beta: 2.23)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Insmed Incorporated's is 2.2254. This would suggest that Insmed Incorporated's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Insmed Incorporated overview

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey. .

Frequently asked questions

What percentage of Insmed Incorporated is owned by insiders or institutions?
Currently 1.367% of Insmed Incorporated shares are held by insiders and 106.959% by institutions.
How many people work for Insmed Incorporated?
Latest data suggests 521 work at Insmed Incorporated.
When does the fiscal year end for Insmed Incorporated?
Insmed Incorporated's fiscal year ends in December.
Where is Insmed Incorporated based?
Insmed Incorporated's address is: 700 US Highway 202/206, Bridgewater, NJ, United States, 08807-1704
What is Insmed Incorporated's ISIN number?
Insmed Incorporated's international securities identification number is: US4576693075
What is Insmed Incorporated's CUSIP number?
Insmed Incorporated's Committee on Uniform Securities Identification Procedures number is: 457669109

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site